Filing Details
- Accession Number:
- 0001859061-22-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-19 06:56:16
- Reporting Period:
- 2022-08-16
- Accepted Time:
- 2022-08-19 06:56:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1840439 | Biomea Fusion Inc. | BMEA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1859061 | A2A Pharmaceuticals, Inc. | 82 South Road Chilmark MA 02535 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-08-16 | 30,684 | $13.87 | 4,300,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Shares were sold in multiple transaction in a range of prices from 13.65 to 14.01 and an average price of 13.872. Details of the specific trades are available upon request
Billionaire Hedge Funds
